PCOS is chronic endocrine disorder and pave the way for obesity, insulin resistance, Type-2 diabetes, hyperlipidemia, cardiovascular disease, metabolic syndrome and cancer in long term
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Polycystic Ovary Syndrome (PCOS) is frequently seen in women of reproductive age and the diagnosis is based on hyperandrogenism and anovulation.
📊
Key Findings & Data:Polycystic Ovary Syndrome (PCOS) is frequently seen in women of reproductive age and the diagnosis is based on hyperandrogenism and anovulation.
💡
Conclusion & Impact:PCOS is chronic endocrine disorder and pave the way for obesity, insulin resistance, Type-2 diabetes, hyperlipidemia, cardiovascular disease, metabolic syndrome and cancer in long term
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Polycystic Ovary Syndrome (PCOS) is frequently seen in women of reproductive age and the diagnosis is based on hyperandrogenism and anovulation. PCOS is chronic endocrine disorder and pave the way for obesity, insulin resistance, Type-2 diabetes, hyperlipidemia, cardiovascular disease, metabolic syndrome and cancer in long term
Özet
Polikistik Over Sendromu (PKOS), üreme çağındaki kadınlarda sıklıkla görülür ve tanısı hiperandrojenizm ve anovülasyona dayalıdır. PKOS kronik seyredip, uzun dönemde; obezite, insülin direnci, Tip-2 diyabet, hiperlipidemi, sendrom ve kanser gibi sağlık sorunlarına zemin hazırlar. kardiyovasküler hastalık, metabolik
🔖
Cite This Article
YILDIZHAN, B., İLHAN, G. A. (2016). Long Term Health Problems Caused by Polycystic Ovary Syndrome. Van Tıp Dergisi, Cilt: 23 - Sayı: 3, 301–306. https://ajindex.com/articles/334718
Stein IF, Leventhal ML. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 1935; 29: 181-191.
Burghen GA, Givens JR, Kitabchi AE. Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. J Clin Endocrinol Metab 1980; 50(1): 113-116. 3.Nestler JE. Polycystic ovary syndrome: a disorder for the generalist. Fertil Steril 1998; 70(5): 811-812. 4.Goldzıeher Jw, Green Ja. The polycystic ovary. I. Clinical and histologic features. J Clin Endocrinol Metab 1962; 22: 325-338 5.Asuncion M, Calvo RM, San Millan JL, Sancho J, Avila S, Escobar-Morreale HF. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J. Clin. Endocrinol. Metab 200; 85(7): 2434-2438. 6.Harwood K, Vuguin P, DiMartino-Nardi J. Current Approaches to the Diagnosis and Treatment of Polycystic Ovarian Syndrome in Youth. Horm Res 2007; 68(5): 209-217. 7.Kiddy DS, Sharp PS, White DM, Scanlon MF, Mason HD, Bray CS, et al. Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: an analysis of 263 consecutive cases. Clin Endocrinol (Oxf) 1990; 32(2): 213-220. 8.Speroff L, Class RH, Kase NG. Clinical Gynecologic Endocrinology and Infertility. 7. th ed, Williams and Wilkins, Philadelphia 2005; 78: 465-491. 9.Wang JX, Davies MJ, Norman RJ. Polycystic ovarian syndrome and the risk of spontaneous abortion following assisted reproductive technology treatment. Hum Reprod 2001; 16(12): 2606-2609.
Dunaif A, Wu X, Lee A, Diamanti-Kandarakis E. Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome(PCOS). Am J Physiol Endocrinol Metab 2001; 281(2): E392-399. Dunaif A. Insulin action in the polycystic ovary syndrome. Endocrinol Metab Clin North Am 1999; 28(2): 341-359. Acién P, Quereda F, Matallín P, Villarroya E, López-Fernández JA, Acién M, et al. Insulin, androgens, and obesity in women with and without polycystic ovary syndrome: a heterogeneous group of disorders. Fertil Steril 1999; 72(1): 32-40. De Leo V, la Marca A, Petraglia F. Insulin-lowering agents in the management of polycystic ovary syndrome. Endocr Rev 2003; 24(5): 633-667.
Speroff L, Class RH, Kase NG. Clinical Gynecologic Endocrinology and Infertility. 7. th ed, Williams and Wilkins, Philadelphia 2005; 78: 465- 491. Robinson S, Kiddy D, Gelding SV, Willis D, Niththyananthan R, Bush A, et al. The relationship of insulin insensitivity to menstrual pattern in w